{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:12:54Z","timestamp":1765368774534},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T00:00:00Z","timestamp":1323302400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1002295","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T21:49:57Z","timestamp":1323380997000},"page":"e1002295","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Structural Insights into the Inhibition of Cytosolic 5\u2032-Nucleotidase II (cN-II) by Ribonucleoside 5\u2032-Monophosphate Analogues"],"prefix":"10.1371","volume":"7","author":[{"given":"Franck","family":"Gallier","sequence":"first","affiliation":[]},{"given":"Perrine","family":"Lallemand","sequence":"additional","affiliation":[]},{"given":"Ma\u00efa","family":"Meurillon","sequence":"additional","affiliation":[]},{"given":"Lars P.","family":"Jordheim","sequence":"additional","affiliation":[]},{"given":"Charles","family":"Dumontet","sequence":"additional","affiliation":[]},{"given":"Christian","family":"P\u00e9rigaud","sequence":"additional","affiliation":[]},{"given":"Corinne","family":"Lionne","sequence":"additional","affiliation":[]},{"given":"Suzanne","family":"Peyrottes","sequence":"additional","affiliation":[]},{"given":"Laurent","family":"Chaloin","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2011,12,8]]},"reference":[{"key":"ref1","first-page":"385","article-title":"Nucleotidase and its relation to the deamination of nucleotides in the heart and the muscles.","volume":"16","author":"MJ Reis","year":"1934","journal-title":"Bull Soc Chim Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2005.01.003","article-title":"The 5\u2032-nucleotidases as regulators of nucleotide and drug metabolism.","volume":"107","author":"SA Hunsucker","year":"2005","journal-title":"Pharmacol Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"46195","DOI":"10.1074\/jbc.R300032200","article-title":"Mammalian 5\u2032-nucleotidases.","volume":"278","author":"V Bianchi","year":"2003","journal-title":"J Biol Chem"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.febslet.2005.05.014","article-title":"Regulation and activity of cytosolic 5\u2032-nucleotidase II. A bifunctional allosteric enzyme of the Haloacid Dehalogenase superfamily involved in cellular metabolism.","volume":"579","author":"AS Bretonnet","year":"2005","journal-title":"FEBS Lett"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1042\/bj2050503","article-title":"Nucleoside exchange catalysed by the cytoplasmic 5\u2032-nucleotidase.","volume":"205","author":"Y Worku","year":"1982","journal-title":"Biochem J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1042\/bj3170797","article-title":"Mechanism of the reaction catalysed by cytosolic 5\u2032-nucleotidase\/phosphotransferase: formation of a phosphorylated intermediate.","volume":"317","author":"C Baiocchi","year":"1996","journal-title":"Biochem J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/bj2850345","article-title":"5\u2032-Nucleotidase: molecular structure and functional aspects.","volume":"285","author":"H Zimmermann","year":"1992","journal-title":"Biochem J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"18759","DOI":"10.1016\/S0021-9258(18)37348-4","article-title":"High Km soluble 5\u2032-nucleotidase from human placenta. Properties and allosteric regulation by IMP and ATP.","volume":"263","author":"J Spychala","year":"1988","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0167-4838(96)00021-0","article-title":"Synergistic action of ADP and 2,3-bisphosphoglycerate on the modulation of cytosolic 5\u2032-nucleotidase.","volume":"1294","author":"R Pesi","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1046\/j.1471-4159.1998.71031241.x","article-title":"IMP-GMP 5\u2032-nucleotidase from rat brain: activation by polyphosphates.","volume":"71","author":"AF Marques","year":"1998","journal-title":"J Neurochem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jmb.2011.02.059","article-title":"Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5\u2032-Nucleotidase II.","volume":"408","author":"K Wallden","year":"2011","journal-title":"J Mol Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0163-7258(00)00053-X","article-title":"Tumor-promoting functions of adenosine.","volume":"87","author":"J Spychala","year":"2000","journal-title":"Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/abbi.2001.2676","article-title":"Human erythrocyte pyrimidine 5\u2032-nucleotidase, PN-I.","volume":"397","author":"A Amici","year":"2002","journal-title":"Arch Biochem Biophys"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0006-2952(03)00290-9","article-title":"Cytosolic and mitochondrial deoxyribonucleotidases: activity with substrate analogs, inhibitors and implications for therapy.","volume":"66","author":"C Mazzon","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1046\/j.1365-2141.2002.03538.x","article-title":"In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.","volume":"117","author":"CM Galmarini","year":"2002","journal-title":"Br J Haematol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.111.182873","article-title":"Genetic variants in NT5C2 are associated with its expression and cytarabine sensitivity in HapMap cell lines and in AML patients.","volume":"339","author":"AK Mitra","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.leukres.2007.01.018","article-title":"Clinical significance of high-Km 5\u2032-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome.","volume":"31","author":"K Suzuki","year":"2007","journal-title":"Leuk Res"},{"key":"ref18","article-title":"Relationship of 5\u2032-nucleotidase and deoxynucleoside kinase activity to the clinical activity of cladribine and fludarabine.","author":"F Albertioni","year":"2007"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.bbamcr.2008.03.018","article-title":"Knockdown of cytosolic 5\u2032-nucleotidase II (cN-II) reveals that its activity is essential for survival in astrocytoma cells.","volume":"1783","author":"MG Careddu","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/sj.bjp.0707515","article-title":"Towards the development of universal, fast and highly accurate docking\/scoring methods: a long way to go.","volume":"153","author":"N Moitessier","year":"2008","journal-title":"Br J Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/prot.21082","article-title":"Protein-ligand docking: current status and future challenges.","volume":"65","author":"SF Sousa","year":"2006","journal-title":"Proteins"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.","volume":"49","author":"RA Friesner","year":"2006","journal-title":"J Med Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm050362n","article-title":"A critical assessment of docking programs and scoring functions.","volume":"49","author":"GL Warren","year":"2006","journal-title":"J Med Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1747-0285.2005.00327.x","article-title":"Use of an induced fit receptor structure in virtual screening.","volume":"67","author":"W Sherman","year":"2006","journal-title":"Chem Biol Drug Des"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ejoc.200600562","article-title":"Ex-chiral-pool synthesis of beta-hydroxyphosphonate nucleoside analogues.","volume":"6","author":"F Gallier","year":"2007","journal-title":"Eur J Org Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nsb846","article-title":"Crystal structure of a human mitochondrial deoxyribonucleotidase.","volume":"9","author":"A Rinaldo-Matthis","year":"2002","journal-title":"Nat Struct Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/15257770500458027","article-title":"F-ara-AMP is a substrate of cytoplasmic 5\u2032-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation.","volume":"25","author":"LP Jordheim","year":"2006","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ab.2005.10.027","article-title":"Intracellular nucleotide and nucleotide sugar contents of cultured CHO cells determined by a fast, sensitive, and high-resolution ion-pair RP-HPLC.","volume":"348","author":"N Kochanowski","year":"2006","journal-title":"Anal Biochem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/ac00039a010","article-title":"Analysis of free intracellular nucleotides using high-performance capillary electrophoresis.","volume":"64","author":"M Ng","year":"1992","journal-title":"Anal Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00928361","article-title":"Physiological concentrations of purines and pyrimidines.","volume":"140","author":"TW Traut","year":"1994","journal-title":"Mol Cell Biochem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1021\/ci9004749","article-title":"Combining 3-D quantitative structure-activity relationship with ligand based and structure based alignment procedures for in silico screening of new hepatitis C virus NS5B polymerase inhibitors.","volume":"50","author":"I Musmuca","year":"2010","journal-title":"J Chem Inf Model"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10822-010-9381-1","article-title":"Trainable structure-activity relationship model for virtual screening of CYP3A4 inhibition.","volume":"24","author":"R Didziapetris","year":"2010","journal-title":"J Comput Aided Mol Des"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1021\/jm901851t","article-title":"Development of potent and selective inhibitors of ecto-5\u2032-nucleotidase based on an anthraquinone scaffold.","volume":"53","author":"Y Baqi","year":"2010","journal-title":"J Med Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11302-008-9103-5","article-title":"Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases).","volume":"5","author":"Y Baqi","year":"2009","journal-title":"Purinergic Signal"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1016\/j.tetlet.2006.08.116","article-title":"Use of microwave irradiation for sugar and nucleoside phosphonates synthesis.","volume":"47","author":"S Peyrottes","year":"2006","journal-title":"Tetrahedron Letters"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1016\/j.tet.2009.05.064","article-title":"Developing an efficient route to the synthesis of nucleoside 1-alkynylphosphonates.","volume":"65","author":"M Meurillon","year":"2009","journal-title":"Tetrahedron"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/cmdc.201100068","article-title":"5\u2032,6\u2032-Nucleoside Phosphonate Analogues Architecture: Synthesis and Comparative Evaluation towards Metabolic Enzymes.","volume":"6","author":"F Gallier","year":"2011","journal-title":"ChemMedChem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.282.5394.1669","article-title":"Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance.","volume":"282","author":"H Huang","year":"1998","journal-title":"Science"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1006\/bbrc.1993.1339","article-title":"A comparison of the conformations of the 5\u2032-triphosphates of zidovudine (AZT) and thymidine bound to HIV-1 reverse transcriptase.","volume":"191","author":"GR Painter","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00527633","article-title":"Molecular orbital calculations on the conformation of nucleic acids and their constituents. VII. Conformation of the sugar ring in \u03b2-nucleosides: the pseudorotational representation.","volume":"30","author":"A Saran","year":"1973","journal-title":"Theoret chim Acta (Berl)"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"17828","DOI":"10.1074\/jbc.M700917200","article-title":"Crystal structure of human cytosolic 5\u2032-nucleotidase II: insights into allosteric regulation and substrate recognition.","volume":"282","author":"K Wallden","year":"2007","journal-title":"J Biol Chem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/jcc.21287","article-title":"CHARMM: the biomolecular simulation program.","volume":"30","author":"BR Brooks","year":"2009","journal-title":"J Comput Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/1097-0282(2000)56:4<257::AID-BIP10029>3.0.CO;2-W","article-title":"Development and current status of the CHARMM force field for nucleic acids.","volume":"56","author":"AD MacKerell Jr","year":"2000","journal-title":"Biopolymers"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/bj3040641","article-title":"Partial purification of a type eta protein kinase C from murine brain: separation from other protein kinase C isoenzymes and characterization.","volume":"304","author":"R Zang","year":"1994","journal-title":"Biochem J"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","article-title":"Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges.","volume":"36","author":"J Gasteiger","year":"1980","journal-title":"Tetrahedron"},{"key":"ref46","article-title":"The PyMOL Molecular Graphics System DeLano Scientific LLC, Palo Alto, CA.","author":"WL DeLano","year":"2008"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics.","volume":"14","author":"W Humphrey","year":"1996","journal-title":"J Mol Graph"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.","volume":"8","author":"AC Wallace","year":"1995","journal-title":"Protein Eng"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1006\/jmbi.1994.1334","article-title":"Satisfying hydrogen bonding potential in proteins.","volume":"238","author":"IK McDonald","year":"1994","journal-title":"J Mol Biol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1046\/j.1432-1327.1999.00099.x","article-title":"ATP and phosphate reciprocally affect subunit association of human recombinant High Km 5\u2032-nucleotidase. Role for the C-terminal polyglutamic acid tract in subunit association and catalytic activity.","volume":"259","author":"J Spychala","year":"1999","journal-title":"Eur J Biochem"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002295","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T13:09:39Z","timestamp":1639919379000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002295"}},"subtitle":[],"editor":[{"given":"James M.","family":"Briggs","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2011,12,8]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1002295","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,8]]}}}